Department of Pediatrics, Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, NY.
Division of Allergy and Immunology, Department of Pediatrics, University of California, San Diego, Rady Children's Hospital, San Diego, Calif.
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3249-3256. doi: 10.1016/j.jaip.2021.07.029.
Eosinophilic esophagitis (EoE) is an antigen-triggered chronic disease of increasing prevalence in children and adults. Untreated or therapy-resistant EoE leads to complications of esophageal food impactions and luminal narrowing. The past decade has seen a number of new clinical trials for EoE therapies including elimination diets, proton pump inhibitors, swallowed topical corticosteroids, and biologics. In this review, we comment on the current state of the art for dietary and pharmacologic management of EoE and the need for future clinical trials to help tailor therapies to individual patients with this chronic disease.
嗜酸性粒细胞性食管炎 (EoE) 是一种抗原触发的慢性疾病,在儿童和成人中的发病率不断增加。未经治疗或治疗抵抗的 EoE 会导致食管食物嵌塞和管腔狭窄等并发症。在过去的十年中,已经有许多针对 EoE 治疗的新临床试验,包括排除饮食、质子泵抑制剂、口服局部皮质类固醇和生物制剂。在这篇综述中,我们评论了 EoE 的饮食和药物治疗的最新进展,以及未来临床试验的必要性,以帮助针对这种慢性疾病的个体患者定制治疗方案。